Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 10

Insights on the LANCE Pilot Study on Lung LCNEC

,

Panelists discuss their impressions of the LANCE pilot study for atezolizumab in lung large cell neuroendocrine carcinoma (LCNEC) and its potential impact on treatment strategies.

EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
EP. 3: The Pathological Diagnosis of Lung LCNEC
EP. 4: Biomarker Testing Strategies for Lung LCNEC
EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
EP. 6: Lung LCNEC Diagnostic Challenges
EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
EP. 8: Lung LCNEC Disease Histology and Prognosis
EP. 9: The Role of DLL3 in LCNEC of the Lung
Now Viewing
EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
  • Please share your impressions of the LANCE pilot study for atezolizumab in LCNEC.

Related Content:

Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)
The Role of DLL3 in LCNEC of the Lung
Lung LCNEC Disease Histology and Prognosis
A Multidisciplinary Approach to Managing Lung LCNEC